Skip to content

An observational study of patients with apparent resistant hypertension in Belgium

Multi-center Cross-sectional TReatment Evaluation of Apparent resistant hyperTension in Belgium (TREAT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN33435469
Enrollment
390
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Resistant hypertension Circulatory System Hypertension

Interventions

All participants attend an appointment to see their general practitioner, who is asked to record the following information: 1. Number of the patient in the study (1 to 15) 2. Age, sex, weight and heig

Sponsors

Servier Benelux
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged =18 years 2. Referred to specialized hospital centre for apparent resistant (non-controlled) hypertension 3. Office (consultation) systolic blood pressure =140 mmHg and/or office diastolic blood pressure =90 mmHg 4. Treated with =3 antihypertensive drugs

Exclusion criteria

Exclusion criteria: 1. Patients referred to specialized hospital centre with suspicion of secondary hypertension

Design outcomes

Primary

MeasureTime frame
1. Systolic and diastolic blood pressure values measured according to the general practitioners’ standard operating procedure during the consultation

Secondary

MeasureTime frame
1. Number of antihypertensive drugs taken prior to the consultation assessed from medical records during the consultation 2. Cardiovascular risk of on-treatment patients in Belgium measured using medical records and patient anamnesis during the consultation 3. Types of antihypertensive used in Belgium assessed from medical records during the consultation 4. Self-reported adherence to treatment measured using the Hill-Bone Scale during the consultation

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026